Adequan i.m. for Horses | Free Shipping | EntirelyPets Rx
Licensed U.S. Pet Pharmacy | Verified Pharmacy
Mobile Menu
Search Submit
My Account
View Cart 0
Adequan i.m. for Horses (Polysulfated Glycosaminoglycan)

Adequan i.m. for Horses (Polysulfated Glycosaminoglycan)

Item#
FREE SHIPPING Over $59! * Pet Food & Other Exclusions
1. Select count:
QTY:-+

Price too low to show

Add to cart to see low price
Prescription Required
  1. We'll ask for your vet's info during check out.
  2. We'll verify your prescription and ship your order!
Recurring Saings in EprxAUTOSHIP & SAVE[Details]
Recurring Saings in EprxAUTOSHIP & SAVE[Details]
$45.49Reg $65.95
$183.49Reg $199.95
$492.99Reg $640.99
$517.99Reg $599.95
  • Description
  • Ingredients
  • Directions
  • FAQ
  • Reviews

Description

If you are searching for a product that treats both the symptoms and the underlying degenerative disease process of horse's joint problems, Adequan i.m. Single Dose may be a good choice.

First, Adequan has important anti-inflammatory effects, so it is able to provide relief from the symptoms of joint damage: heat, swelling, pain and lameness. And Adequan can be found in synovial fluid at full herapeutic levels within only two hours of an intramuscular injection. Also, Adequan is a product with potent ability to block the action of the destructive enzymes that threaten to perpetuate the joint inflammation, attack the cartilage and break down synovial fluid.

Second, Adequan stimulates the synovial membrane to manufacture new, viscous synovial fluid to replace the thin fluid that was produced when the joint became injured. By improving this fluid, Adequan helps the joint regain its ability to lubricate and guard itself against further inflammation, and helps reestablish nutrition to the cartilage. And, Adequan attaches itself to damaged cartilage where it has a positive effect on cartilage metabolism. This should favor the cartilage repair process.

Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components. You are no longer just treating symptoms: you're doing something to help stop the degenerative process.

Indications

Adequan i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

Key Benefits

  • The only joint treamtent with proven results
  • Fast results within hours
  • Easy-to-use with a single injection

Prescription Required

Ingredients

Active Ingredient

Polysulfated Glycosaminoglycan (PSGAG), 500 mg / 5 mL

Directions

View Adequan i.m. package label.

Dosage and Administration

The recommended dose of Adequan i.m. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan i.m. with other drugs or solvents.

Contraindications

There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.

Warnings

Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.

Precautions

The safe use of Adequan i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.

Animal Safety

Toxicity studies were conducted in horses. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.

Storage

Store and 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). Keep out of reach of children and animals. Discard unused portion. Dispose of spent needles in accordance with all federal, state, and local environmental laws.

FAQ

Adequan i.m. (polysulfated glycosaminoglycan) is the only FDA-Approved equine intramuscular PSGAG prescription available. It is recommended for intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
Adequan i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

As the only PSGAG joint prescription, Adequan i.m. has a mode of action that helps treat degenerative joint disease (DJD) in multiple ways to keep joints moving. It is proven to:

  • Relieve lameness caused by swelling and inflammation associated with joint disease
  • Restore synovial lubrication that facilitates movement and reduces local inflammation
  • Repair cartilage and rapidly aid in the production of new cartilage
  • Reverse the disease cycle that leads to the loss of cartilage components by inhibiting harmful enzymes that attack cartilage and synovial fluid

Ask your veterinarian if Adequan i.m. is the right choice for your horse

Adequan i.m. is an FDA-Approved drug for the treatment of DJD and traumatic joint dysfunction. As required by the FDA, safety and efficacy studies were contudcted on Adequan i.m. without concomitant used of additional products. Adequan i.m. successfully achieved FDA-apprroval without use of additional oral joint health (OJS) products.
There are no age or breed restrictions.
No. The safe use of Adequan i.m. in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated. Please contact your prescribing veterinarian for assistance.
No. Adequan i.m. has not been studied for safety or efficacy in foals, minis, drafts, or aged horses. Please contact your prescribing veterinarian for assistance.
There are many supplements, medical devices, and over-the-counter products making claims similar to Adequan i.m. However, most of these products are only supported by testimonial statements and do not have the structured and qualified product testing and trials Adequan i.m. completed to obtain FDA-approval.
There are no known contraindications to the use of intramuscular Polysulfated Glycoasminoglycan. Do not use in horses showing a hypersensitivity to PSGAG.
The safety of Adequan i.m. in horses used for breeding, purposes, during pregnancy, or in lactating mares has not been evaluated.
Adequan i.m. should not be used in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.

Customers Who Bought Also Bought